Multicentre Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Nephropathy.

Abroad (travel likely)RecruitingPHASE4

Conditions

Glomerulonephritis · Immunoglobulin A Nephropathy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

francesco paolo Schena, Bari, BA, Italy
Contact: Study coordinator (Francesco P Schena, MD) · paolo.schena@uniba.it · 3336771291
francesco paolo Schena, Bari, BA, Italy
Contact: Study coordinator (francesco P Schena) · fp.schena@gmail.com · 3336771291

Study leads

Francesco P Schena
Study Chair
Fondazione Schena
francesco P Schena
Study Director
Fondazione Schena

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN

Glomerulonephritis, IGA · Immunoglobulin A Nephropathy

IsraelRecruitingPHASE2

Birmingham, United States · Los Angeles, United States

Effect of Huaier Granule on the Treatment of Idiopathic Membranous Nephropathy

Nephropathy · Glomerular Diseases · Idiopathic Membranous Nephropathy

Abroad (travel likely)RecruitingPHASE4

Beijing, China

The Clinical Application of Artificial Intelligence Assisted Renal Biopsy Diagnosis System.

Chronic Glomerulonephritis · Chronic Kidney Disease

Abroad (travel likely)Recruiting

Guangzhou, China · Guangzhou, China

Clinical Study of Rituximab for the Treatment for Idiopathic Membranous Nephropathy with Nephrotic Syndrome

Glomerulonephritis, Membranous · Nephrotic Syndrome，Idiopathic

Abroad (travel likely)RecruitingPHASE3

Anjo, Japan · Kasugai, Japan